Nanotechnology Characterization Laboratory (NCL)
Project Brief
Eliminating suffering and death from cancer requires an unprecedented collaborative effort that leverages resources from government, industry, and academia. Working in concert with the National Institute of Standards and Technology (NIST) and the U.S. Food and Drug Administration (FDA), the National Cancer Institute (NCI) established the Nanotechnology Characterization Laboratory to perform preclinical efficacy and toxicity testing of nanoparticles.
Client
Center for Strategic Scientific Initiatives (CSSI), National Cancer Institute (NCI), National Institutes of Health (NIH)
Project
Nanotechnology Characterization Laboratory (NCL)
Product
https://ncl.cancer.gov/
Visual A
